Venus Concept (VERO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting of stockholders is scheduled for February 14, 2025, to consider a single proposal: authorizing the board to effect a reverse stock split at a ratio between 1-for-5 and 1-for-16, at the board's discretion, within one year of approval.
The reverse stock split aims to help regain compliance with Nasdaq's minimum bid price requirement, following a notice of non-compliance and an extension to April 7, 2025, to cure the deficiency.
The board recommends voting in favor of the proposal, emphasizing the risk of delisting and reduced liquidity if the split is not approved.
Voting matters and shareholder proposals
Only one proposal is on the agenda: granting the board authority to implement a reverse stock split at a ratio between 1-for-5 and 1-for-16, without reducing the authorized number of shares.
Stockholders of record as of December 31, 2024, are eligible to vote, with voting available online, by phone, or by mail.
Approval requires a majority of shares present or represented by proxy; abstentions and broker non-votes count as votes against.
Board of directors and corporate governance
The board has sole discretion to determine the timing and ratio of the reverse split within the approved range and may abandon the action if deemed not in the best interest of stockholders.
No director or executive officer has a substantial interest in the proposal beyond their share ownership.
Latest events from Venus Concept
- Revenue down 17% year-over-year, but debt reduced and margin improved amid ongoing risks.VERO
Q2 20241 Feb 2026 - Q3 2024 revenue fell 15% year-over-year as debt was cut by 54% and losses persisted.VERO
Q3 202414 Jan 2026 - Revenue fell 13% in Q4 and 15% for FY24; debt cut by 47% and Q1 2025 revenue to exceed $14M.VERO
Q4 202424 Dec 2025 - Shelf registration enables up to $30.4M in securities sales for global medical technology expansion.VERO
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and key share issuance proposals.VERO
Proxy Filing1 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and major share issuances.VERO
Proxy Filing1 Dec 2025 - Vote sought to authorize a reverse stock split to maintain Nasdaq listing and enhance share value.VERO
Proxy Filing1 Dec 2025 - Approval sought for share issuance tied to convertible notes after major debt restructuring.VERO
Proxy Filing1 Dec 2025 - Amended registration statement for a public offering, with auditor consent and executive sign-off.VERO
Registration Filing29 Nov 2025